SHSE:688137 (China)
Â
Class A
Â¥
29.90
(-0.1%)
Sep 12
Business Description
Suzhou Novoprotein Scientific Co Ltd
ISIN : CNE100005NZ4
Share Class Description:
SHSE:688137: Class ACompare
Compare
Traded in other countries / regions
688137.China IPO Date
2022-09-29Description
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes and reagents, Production and sales, and provide related technical services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.96 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -4.29 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 9.7 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 151.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.56 | |||||
| 9-Day RSI | 48.83 | |||||
| 14-Day RSI | 46.97 | |||||
| 6-1 Month Momentum % | -18.17 | |||||
| 12-1 Month Momentum % | -38.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 23.75 | |||||
| Quick Ratio | 22.83 | |||||
| Cash Ratio | 13.12 | |||||
| Days Inventory | 677.61 | |||||
| Days Sales Outstanding | 178.7 | |||||
| Days Payable | 143.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.67 | |||||
| Forward Dividend Yield % | 1.67 | |||||
| 5-Year Yield-on-Cost % | 1.67 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.85 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.53 | |||||
| Operating Margin % | -17.8 | |||||
| Net Margin % | -6.1 | |||||
| FCF Margin % | -2.23 | |||||
| ROE % | -0.39 | |||||
| ROA % | -0.37 | |||||
| ROIC % | -1.39 | |||||
| 3-Year ROIIC % | -14.29 | |||||
| ROC (Joel Greenblatt) % | -2.97 | |||||
| ROCE % | -0.79 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 114.12 | |||||
| PS Ratio | 15.52 | |||||
| PB Ratio | 0.98 | |||||
| Price-to-Tangible-Book | 0.98 | |||||
| Price-to-Operating-Cash-Flow | 42.96 | |||||
| EV-to-EBIT | -59.2 | |||||
| EV-to-EBITDA | -59.2 | |||||
| EV-to-Revenue | 7.56 | |||||
| EV-to-FCF | -331.27 | |||||
| Price-to-Graham-Number | 2.23 | |||||
| Price-to-Net-Current-Asset-Value | 1.1 | |||||
| Price-to-Net-Cash | 2.13 | |||||
| Earnings Yield (Greenblatt) % | -1.69 | |||||
| FCF Yield % | -0.15 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers